tradingkey.logo

Integra Lifesciences Holdings Corp

IART
11.260USD
+0.380+3.49%
終値 02/06, 16:00ET15分遅れの株価
876.42M時価総額
損失額直近12ヶ月PER

Integra Lifesciences Holdings Corp

11.260
+0.380+3.49%

詳細情報 Integra Lifesciences Holdings Corp 企業名

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, plastics and surgical reconstruction products, and others.

Integra Lifesciences Holdings Corpの企業情報

企業コードIART
会社名Integra Lifesciences Holdings Corp
上場日Aug 16, 1995
最高経営責任者「CEO」Poul (Mojdeh)
従業員数4396
証券種類Ordinary Share
決算期末Aug 16
本社所在地1100 Campus Road
都市PRINCETON
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号08540
電話番号16092750500
ウェブサイトhttps://www.integralife.com/
企業コードIART
上場日Aug 16, 1995
最高経営責任者「CEO」Poul (Mojdeh)

Integra Lifesciences Holdings Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
+26531.00%
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
89.14K
+19200.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
58.58K
-2561.00%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
35.79K
-4282.00%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
21.94K
+8684.00%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Robert T. Davis, Jr.
Mr. Robert T. Davis, Jr.
Executive Vice President, President - Tissue Technologies
Executive Vice President, President - Tissue Technologies
--
--
Ms. Barbara B. Hill
Ms. Barbara B. Hill
Independent Presiding Director
Independent Presiding Director
--
--
Mr. Eric I. Schwartz
Mr. Eric I. Schwartz
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
--
--
Mr. Michael J. Mcbreen
Mr. Michael J. Mcbreen
Executive Vice President, President - Codman Specialty Surgical
Executive Vice President, President - Codman Specialty Surgical
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Christian S. (Chris) Schade
Mr. Christian S. (Chris) Schade
Independent Director
Independent Director
90.03K
+26531.00%
Dr. Keith Bradley, Ph.D.
Dr. Keith Bradley, Ph.D.
Independent Director
Independent Director
89.14K
+19200.00%
Ms. Lea Daniels Knight
Ms. Lea Daniels Knight
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
58.58K
-2561.00%
Mr. Jeffrey Mosebrook
Mr. Jeffrey Mosebrook
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
35.79K
-4282.00%
Mr. Harvinder Singh
Mr. Harvinder Singh
Executive Vice President, President - International Business
Executive Vice President, President - International Business
21.94K
+8684.00%
Dr. Stuart M. Essig, Ph.D.
Dr. Stuart M. Essig, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Neurosurgery
201.56M
50.13%
Wound Reconstruction and Care
83.99M
20.89%
Instruments
50.15M
12.47%
ENT
40.87M
10.16%
Private Label
25.49M
6.34%
地域別USD
会社名
収益
比率
United States
295.85M
73.58%
Europe
42.89M
10.67%
Asia Pacific
42.68M
10.62%
Rest of World
20.64M
5.13%
事業別
地域別
事業別USD
会社名
収益
比率
Neurosurgery
201.56M
50.13%
Wound Reconstruction and Care
83.99M
20.89%
Instruments
50.15M
12.47%
ENT
40.87M
10.16%
Private Label
25.49M
6.34%

株主

更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
11.92%
TRU ST Partnership, L.P.
10.93%
Rubric Capital Management LP
9.83%
The Vanguard Group, Inc.
9.13%
Fuller & Thaler Asset Management Inc.
5.03%
他の
53.16%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
11.92%
TRU ST Partnership, L.P.
10.93%
Rubric Capital Management LP
9.83%
The Vanguard Group, Inc.
9.13%
Fuller & Thaler Asset Management Inc.
5.03%
他の
53.16%
種類
株主統計
比率
Investment Advisor
36.64%
Investment Advisor/Hedge Fund
36.54%
Hedge Fund
18.48%
Corporation
10.93%
Individual Investor
3.20%
Research Firm
2.31%
Pension Fund
1.48%
Bank and Trust
0.40%
Sovereign Wealth Fund
0.04%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
583
75.09M
96.41%
-24.67M
2025Q3
583
73.55M
94.42%
-25.07M
2025Q2
600
89.38M
114.72%
-18.72M
2025Q1
635
87.01M
111.97%
-18.30M
2024Q4
636
81.93M
106.10%
-20.27M
2024Q3
638
82.93M
106.93%
-12.58M
2024Q2
628
84.82M
107.92%
-1.75M
2024Q1
613
79.36M
101.18%
-3.69M
2023Q4
597
79.81M
101.26%
-5.74M
2023Q3
592
81.88M
100.31%
-3.94M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
9.29M
11.92%
-146.58K
-1.55%
Sep 30, 2025
TRU ST Partnership, L.P.
8.52M
10.93%
--
--
Feb 28, 2025
Rubric Capital Management LP
7.65M
9.83%
+300.00K
+4.08%
Sep 30, 2025
The Vanguard Group, Inc.
7.29M
9.36%
-217.24K
-2.89%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
3.91M
5.03%
+21.91K
+0.56%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.18M
4.09%
+267.13K
+9.16%
Sep 30, 2025
Invesco Advisers, Inc.
3.18M
4.09%
+3.31K
+0.10%
Sep 30, 2025
State Street Investment Management (US)
2.79M
3.58%
-35.57K
-1.26%
Sep 30, 2025
Boston Management and Research
2.74M
3.52%
--
--
Sep 30, 2025
Paradigm Capital Management, Inc.
2.53M
3.25%
+348.30K
+15.97%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Neuroscience and Healthcare ETF
1.44%
State Street SPDR S&P Health Care Equipment ETF
1.39%
ROBO Global Healthcare Technology & Innovation ETF
1.02%
Invesco S&P SmallCap Health Care ETF
0.49%
Invesco NASDAQ Future Gen 200 ETF
0.43%
Inspire Small/Mid Cap ESG ETF
0.19%
Royce Quant Small-Cap Quality Value ETF
0.13%
Principal U.S. Small-Cap ETF
0.13%
iShares S&P Small-Cap 600 Value ETF
0.12%
State Street SPDR S&P 600 Small Cap Value ETF
0.11%
詳細を見る
iShares Neuroscience and Healthcare ETF
比率1.44%
State Street SPDR S&P Health Care Equipment ETF
比率1.39%
ROBO Global Healthcare Technology & Innovation ETF
比率1.02%
Invesco S&P SmallCap Health Care ETF
比率0.49%
Invesco NASDAQ Future Gen 200 ETF
比率0.43%
Inspire Small/Mid Cap ESG ETF
比率0.19%
Royce Quant Small-Cap Quality Value ETF
比率0.13%
Principal U.S. Small-Cap ETF
比率0.13%
iShares S&P Small-Cap 600 Value ETF
比率0.12%
State Street SPDR S&P 600 Small Cap Value ETF
比率0.11%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI